Research & Insights
Latest updates in oncology research and medical advancements
019 articles
Filed under Research & Insights
- Research & Insights How a Common Gut Bacterium Contributes to Colorectal Cancer Researchers have identified how a toxin from Bacteroides fragilis damages the intestinal lining and promotes colorectal cancer. Here's what it means for patients.
- Research & Insights Could Your Morning Coffee Help Unlock the Next Breakthrough in Cancer Research? Could a compound in your morning coffee help scientists understand cancer biology? A new Texas A&M study on the NR4A1 receptor explains what it means and what it does not.
- Research & Insights Why Are Healthy Young Non-Smokers Developing Lung Cancer? More young adults, especially women under 50 who never smoked, are being diagnosed with lung cancer. A study of 187 patients points to pesticide residues as one hypothesis under investigatio…
- Research & Insights Emerging Innovation in Oncology: Light-Activated Cancer Cell Destruction A novel technique uses light-activated molecules to destroy cancer cells without drugs or chemotherapy. It's promising, but still preclinical.
- Research & Insights Not All Fats Are Equal: A New Perspective on Pancreatic Cancer Research A Yale School of Medicine study suggests the type of dietary fat may matter in pancreatic cancer: oleic acid accelerated tumour growth, while omega-3 fats slowed it in preclinical models.
- Research & Insights AI-Assisted Mammography: Evidence Suggests ~10% Improvement in Breast Cancer Detection New research suggests AI-assisted mammography may raise breast cancer detection by about 10%; the MASAI trial also cut radiologists' workload by nearly 44% without more false-positive recall…
- Research & Insights Nasal Drops May Offer a Non-Invasive Strategy to Fight Brain Tumors Nasal drops carrying gold nanoparticle-based immunotherapy reached brain tumours in preclinical glioblastoma models, bypassing the blood-brain barrier and suppressing tumour growth.
- Research & Insights New Insight into Prostate Cancer: Targeting Two Enzymes May Improve Treatment Outcomes A new study identifies two enzymes, PDIA1 and PDIA5, that help prostate cancer survive and resist treatment. Inhibiting them destabilised the androgen receptor and killed cancer cells.
- Research & Insights Understanding a New Breakthrough in Lung Cancer Research Clone copy number diversity measures how much the clones inside a lung tumour differ in their DNA. Higher diversity is linked to poorer outcomes, and the ALPACA tool maps these changes.